• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

AvroBio

Biotech

Avrobio hopes to get investors back on gene therapy bandwagon

It’s been a year since Avrobio's Fabry disease program failed. Now, the biotech is ready to reintroduce itself.
Annalee Armstrong Dec 7, 2022 7:30am

Avrobio CEO shares outlook on cell and gene landscape

Sep 30, 2022 12:02pm

Avrobio gene therapy shows signs of durability in rare disorder

Feb 9, 2022 10:46am

Avrobio ditches Fabry, eyes 2023 trials for other gene therapies

Jan 4, 2022 10:08am

Avrobio plans Fabrazyme trial after FDA changes path to market

May 3, 2021 8:55am

Avrobio gene therapy eliminates toxic substrate in Fabry patient

Feb 8, 2021 8:40am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy